bromfenac has been researched along with Cranial Nerve II Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agudo-Barriuso, M; Nadal-Nicolás, FM; Rovere, G; Sobrado-Calvo, P; Vidal-Sanz, M; Villegas-Pérez, MP | 1 |
| Agudo-Barriuso, M; García-Bernal, D; Nadal-Nicolás, FM; Rovere, G; Sobrado-Calvo, P; Vidal-Sanz, M; Villegas-Pérez, MP | 1 |
2 other study(ies) available for bromfenac and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Topical bromfenac transiently delays axotomy-induced retinal ganglion cell loss.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Axotomy; Benzophenones; Bromobenzenes; Cell Count; Cell Survival; Disease Models, Animal; Female; Optic Nerve; Optic Nerve Injuries; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells | 2019 |
Topical Treatment With Bromfenac Reduces Retinal Gliosis and Inflammation After Optic Nerve Crush.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Blotting, Western; Bromobenzenes; Cell Count; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Gliosis; Ophthalmic Solutions; Optic Disk; Optic Nerve Injuries; Optic Neuritis; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells; Tomography, Optical Coherence; Transcription Factor Brn-3A | 2016 |